Tom Groot Kormelink

Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity

Tom Groot Kormelink, Janneke Tekstra, Rogier M. Thurlings et al. · Annals of the Rheumatic Diseases · 2010 · 75 citations · Full text

Medicine, Immunology, Internal Medicine +17

An Association between Neutrophils and Immunoglobulin Free Light Chains in the Pathogenesis of Chronic Obstructive Pulmonary Disease

Saskia Braber, Marco Thio, Bart R. Blokhuis et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 62 citations

Medicine, Immunology, Pathology +17

Non‐digestible oligosaccharides reduce immunoglobulin free light‐chain concentrations in infants at risk for allergy

Bastiaan Schouten, Betty C. A. M. van Esch, Tom Groot Kormelink et al. · Pediatric Allergy and Immunology · 2011 · 49 citations

Life Sciences, Immunology, Pediatrics +17

Immunoglobulin Free Light Chains Are Increased in Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis

Tom Groot Kormelink, Annie Pardo, Karen Knipping et al. · PLoS ONE · 2011 · 47 citations · Full text

Veterinary Medicine, Immunology, Pathology +16

Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation

Tom Groot Kormelink, Desmond G. Powe, Sylvia Kuijpers et al. · Oncotarget · 2014 · 39 citations · Full text

Medicine, Cancer Biology, Oncology +15